A detailed history of New Edge Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 393,886 shares of MRK stock, worth $39.1 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
393,886
Previous 655,574 39.92%
Holding current value
$39.1 Million
Previous $81.2 Million 44.89%
% of portfolio
0.3%
Previous 0.6%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $29.1 Million - $33.7 Million
-261,688 Reduced 39.92%
393,886 $44.7 Million
Q2 2024

Aug 15, 2024

BUY
$123.8 - $132.96 $5.64 Million - $6.06 Million
45,591 Added 7.47%
655,574 $81.2 Million
Q1 2024

May 14, 2024

BUY
$113.24 - $131.95 $2.22 Million - $2.59 Million
19,644 Added 3.33%
609,983 $80.5 Million
Q4 2023

Feb 13, 2024

BUY
$100.18 - $109.02 $3.96 Million - $4.31 Million
39,515 Added 7.17%
590,339 $64.4 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $2.36 Million - $2.62 Million
22,909 Added 4.34%
550,824 $56.7 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $809,035 - $881,812
-7,449 Reduced 1.39%
527,915 $60.9 Million
Q1 2023

May 12, 2023

BUY
$102.94 - $114.86 $873,240 - $974,357
8,483 Added 1.61%
535,364 $57 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $4 Million - $5.13 Million
45,732 Added 9.5%
526,881 $58.4 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $24 Million - $26.9 Million
283,559 Added 143.51%
481,149 $41.4 Million
Q2 2022

Aug 09, 2022

BUY
$83.49 - $94.64 $3.2 Million - $3.63 Million
38,365 Added 24.09%
197,590 $18 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $689,229 - $772,582
9,376 Added 6.26%
159,225 $13.1 Million
Q4 2021

Feb 17, 2022

BUY
$72.28 - $90.54 $5.45 Million - $6.82 Million
75,361 Added 101.17%
149,849 $11.5 Million
Q3 2021

Oct 29, 2021

SELL
$71.68 - $78.83 $1.53 Million - $1.69 Million
-21,412 Reduced 22.33%
74,488 $5.6 Million
Q2 2021

Jul 22, 2021

BUY
$70.31 - $77.77 $421,789 - $466,542
5,999 Added 6.67%
95,900 $7.46 Million
Q1 2021

Apr 26, 2021

SELL
$68.86 - $81.11 $2.64 Million - $3.11 Million
-38,367 Reduced 29.91%
89,901 $6.93 Million
Q4 2020

Jan 27, 2021

SELL
$71.77 - $79.65 $15.2 Million - $16.9 Million
-212,392 Reduced 62.35%
128,268 $10.5 Million
Q3 2020

Nov 03, 2020

BUY
$73.18 - $82.95 $2.03 Million - $2.31 Million
27,801 Added 8.89%
340,660 $28.3 Million
Q2 2020

Jul 29, 2020

BUY
$70.42 - $80.13 $1.02 Million - $1.16 Million
14,517 Added 4.87%
312,859 $24.2 Million
Q1 2020

May 04, 2020

SELL
$63.36 - $87.82 $65,704 - $91,069
-1,037 Reduced 0.35%
298,342 $23 Million
Q4 2019

Jan 31, 2020

BUY
$77.58 - $87.54 $2.21 Million - $2.5 Million
28,530 Added 10.53%
299,379 $27.2 Million
Q3 2019

Nov 06, 2019

BUY
$76.08 - $82.93 $6.44 Million - $7.02 Million
84,600 Added 45.42%
270,849 $22.8 Million
Q2 2019

Aug 05, 2019

BUY
$69.84 - $81.59 $1.51 Million - $1.76 Million
21,621 Added 13.13%
186,249 $15.6 Million
Q1 2019

May 14, 2019

BUY
$69.58 - $79.36 $10.5 Million - $12 Million
150,809 Added 1091.32%
164,628 $13.7 Million
Q1 2019

May 09, 2019

SELL
$69.58 - $79.36 $2 Million - $2.28 Million
-28,782 Reduced 67.56%
13,819 $17,000
Q4 2018

Jan 29, 2019

BUY
$65.24 - $75.71 $102,100 - $118,486
1,565 Added 3.81%
42,601 $3.26 Million
Q3 2018

Oct 29, 2018

BUY
$57.69 - $67.84 $178,723 - $210,168
3,098 Added 8.17%
41,036 $2.91 Million
Q2 2018

Jul 19, 2018

BUY
$50.83 - $59.72 $324,803 - $381,610
6,390 Added 20.25%
37,938 $2.29 Million
Q1 2018

May 11, 2018

BUY
$50.96 - $59.23 $201,699 - $234,432
3,958 Added 14.35%
31,548 $1.68 Million
Q4 2017

Feb 08, 2018

BUY
$51.62 - $61.64 $2,116 - $2,527
41 Added 0.15%
27,590 $1.56 Million
Q3 2017

Nov 13, 2017

SELL
$58.67 - $63.13 $32,092 - $34,532
-547 Reduced 1.95%
27,549 $1.77 Million
Q2 2017

Aug 16, 2017

BUY
N/A
28,096
28,096 $0

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.